Breadcrumb

What's New at the RI-MUHC ?

Spike in peanut and nut anaphylaxis in children at Halloween and Easter

New study suggests education and awareness are needed to help reduce risk of anaphylaxis at specific times of the year

Sleep apnea treatment reduces heart problems in patients with prediabetes, a new study finds

People with prediabetes and obstructive sleep apnea could reduce their daytime resting heart rate and risk of cardiovascular disease by using a CPAP machine at night

Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill

Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery

From silent infection to rapid death: Why are some people more vulnerable to COVID-19?

Scientists discover genetic and immunological causes of 15 percent of life-threatening COVID-19 cases

15,000 COVID-19 tests produced by McGill University and the RI-MUHC: a step toward Canadian self-sufficiency

In July 2020, the McGill University Health Centre’s (MUHC's) Department of Clinical...

Protecting lung cancer patients from COVID-19 – and learning from the experience

A study led by Dr. Nathaniel Bourganim tracked changes in treatment plans

New study of therapy options in metastatic melanoma

RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors

Nip it in the bud: New study will attack SARS-Cov2 where it multiplies

RI-MUHC researchers initiate a clinical trial of ciclesonide to possibly prevent mild cases of COVID-19 from worsening

Serious Flaws in Studies Linking COVID-19 and Air Pollution

Studies have yet to prove this link, say Carleton and McGill University epidemiologists

Systematic testing of groups at increased risk of SARS-CoV-2: an affordable and reasonable approach

In a new cost-analysis study, researchers recommend widespread testing of...

Learn more about the RI-MUHC